Polymorphisms in Genes Involved in the Leptin-Melanocortin Pathway are Associated with Obesity-Related Cardiometabolic Alterations in a Southern Chilean Population
| Primer Autor |
Cerda, Alvaro
|
| Co-autores |
Manriquez, Victor#Aviles, Jorge#Salazar, Luis#Saavedra, Nicolas#Seron, Pamela#Lanas, Fernando#Fajardo, Cristina Moreno#Hirata, Mario Hiroyuki#Crespo Hirata, Rosario Dominguez
|
| Título |
Polymorphisms in Genes Involved in the Leptin-Melanocortin Pathway are Associated with Obesity-Related Cardiometabolic Alterations in a Southern Chilean Population
|
| Editorial |
ADIS INT LTD
|
| Revista |
MOLECULAR DIAGNOSIS & THERAPY
|
| Lenguaje |
en
|
| Resumen |
Background Polymorphisms in genes encoding proteins of the leptin-melanocortin pathway have been associated with obesity. The involvement of these polymorphisms with changes in body mass index (BMI) and anthropometric measures could also imply a contribution to the risk of metabolic syndrome (MetS) and metabolic alterations. We evaluated the relationship of leptin-melanocortin system polymorphisms with obesity, MetS, and other metabolic alterations in Southern Chilean individuals. Methods Two-hundred individuals were grouped as normoweight (BMI 18.0-24.9 kg/m(2)), overweight (BMI 25.0-29.9 kg/m(2)), and obese (BMI C 30 kg/m(2)) or according to MetS status. Anthropometric measures (BMI, abdominal circumference, waist-to-hip ratio [WHR]) and biochemical parameters (glycemia and lipid profile) were evaluated. Polymorphisms LEP rs7799039, LEPR rs1137101, MC3R rs3746619 and rs3827103, and MC4R rs17782313 were evaluated by real-time PCR using allelic discrimination assays. Results LEPR rs1137101 GG genotype was related to reduced risk of obesity (odds ratio [OR] 0.26, 95% confidence interval [CI] 0.08-0.79, p = 0.018) and MetS (OR 0.36, 95% CI 0.15-0.88, p = 0.024), but it was not significant after Bonferroni correction for multiple tests as compared to the AA genotype (p[0.01). Moreover, LEPR rs1137101 allele G (AG + GG) was related to lower BMI and WHR (p < 0.01). Further multiple linear regression analysis demonstrated that this genotype was also responsible for reduced BMI in 2.44 kg/m(2) and WHR in 0.033 units. MC4R rs17782313 allele C (TC + CC) was slightly associated with diminished risk of MetS (OR 0.48, 95% CI 0.23-0.98, p = 0.040) and reduced BMI values in 1.95 kg/m(2) (p < 0.05). Regarding lipid profile, LEPR rs1137101 allele G carriers had lower triglycerides and very-lowdensity lipoprotein (VLDL) cholesterol, whereas individuals carrying the MC4R rs17782313 allele C had higher high-density lipoprotein (HDL) cholesterol (p < 0.01). LEP rs7799039 allele A (GA + AA) was slightly associated with reduced total and low-density lipoprotein (LDL) cholesterol (p < 0.05). Conclusions These results suggest that polymorphisms at LEP, LEPR, and MC4R may be useful biomarkers of obesity-related population.
|
| Tipo de Recurso |
Artículo original
|
| Description |
This investigation was supported by grants from FONDECYT-Chile (No 11150445), Universidad de La Frontera-Chile (DIUFRO # DI15-0017), and CNPq- Brazil (# 462778/2014-2).
Esta investigación fue apoyada por subvenciones de FONDECYT-Chile (No 11150445), Universidad de La Frontera-Chile (DIUFRO
DI15-0017) y CNPq-Brasil (
462778/2014-2).
This investigation was supported by grants from FONDECYT-Chile (No 11150445), Universidad de La Frontera-Chile (DIUFRO
DI15-0017), and CNPq- Brazil (
|
| doi |
10.1007/s40291-017-0306-8
|
| Formato Recurso |
pdf
|
| Ubicación del archivo |
http://dx.doi.org/10.1007/s40291-017-0306-8
|
| Categoría OCDE |
Genetics & Heredity# Pharmacology & Pharmacy
|
| Disciplinas de la OCDE |
Genética y Herencia
Fisiología
Endocrinología y Metabolismo (Incluye Diabetes, Hormonas)
|
| Id de Web of Science |
WOS:000422910300008
|
| Título de la cita (Recomendado-único) |
Polymorphisms in Genes Involved in the Leptin-Melanocortin Pathway are Associated with Obesity-Related Cardiometabolic Alterations in a Southern Chilean Population
|
| Identificador del recurso (Mandatado-único) |
Artículo original
|
| Versión del recurso (Recomendado-único) |
version publicada
|
| Editorial |
ADIS INT LTD
|
| Revista/Libro |
MOLECULAR DIAGNOSIS & THERAPY
|
| Categoría WOS |
Genética y Herencia# Farmacología y farmacia
|
| ISSN |
1177-1062
|
| Idioma |
en
|
| Referencia del Financiador (Mandatado si es aplicable-repetible) |
ANID FONDECYT 11150445#UFRO DI15-0017#CNPq 462778/2014-2
ANID FONDECYT 11150445
URO DI15-0017
CNPq 462778/2014-2
|
| Descripción |
This investigation was supported by grants from FONDECYT-Chile (No 11150445), Universidad de La Frontera-Chile (DIUFRO # DI15-0017), and CNPq- Brazil (# 462778/2014-2).
|
| Formato |
pdf
|
| Tipo de ruta |
hibrida#verde
|
| Access Rights |
metadata
|
| Derechos de acceso |
metadata
|
| Página de inicio (Recomendado-único) |
1631
|
| Página final (Recomendado-único) |
1632
|
- Colecciones
- Colección Publicaciones Científicas